2026 Q1 Portfolio Activity
In 2026 Q1, Ishara Investments LP maintained a portfolio of 56 distinct positions. The most significant new addition was AXSOME THERAPEUTICS INC., now representing 6.56% of the total fund value. They heavily accumulated shares in ULTRAGENYX PHARMACEUTICAL IN, increasing the position by 248.5%. The fund also reduced its exposure to PRAXIS PRECISION MEDICINES I by 48.8%.
Position History
hover any row below to update
Loading…
Ishara Investments LP
AUM $99M
Total Positions
56
Quarter
2026 Q1
Top Holding
PRAX (6.9%)
Top 10 Concentration
50.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 56
Ishara Investments LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 6.88% | 13.48% |
#1
Prev: #1
|
4.8 |
—
|
-17,450 | -43.6% |
P
S
|
22,550 | $7,265,385 |
$294.74
-14.1%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 6.56% | — |
#2
Prev: #—
|
7.6 |
—
|
41,000 | — |
NEW
|
41,000 | $6,929,820 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PRAX
PUT
PRAXIS PRECISIO...
|
PUT Option | 6.25% | — |
#3
Prev: #—
|
7.0 |
—
|
20,500 | — |
NEW
|
20,500 | $6,604,895 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XERS
XERIS BIOPHARMA...
|
Healthcare | 5.63% | 7.18% |
#4
2
Prev: #2
|
5.3 |
—
|
225,000 | 28.1% |
P
S
|
1,025,000 | $5,945,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 5.27% | — |
#5
Prev: #—
|
6.1 |
—
|
276,750 | — |
NEW
|
276,750 | $5,570,978 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 5.05% | 5.86% |
#6
2
Prev: #4
|
2.5 |
—
|
9,000 | 2.5% |
P
S
|
369,000 | $5,335,740 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 4.39% | 6.80% |
#7
4
Prev: #3
|
2.3 |
—
|
-18,000 | -18.0% |
P
S
|
82,000 | $4,632,180 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 4.11% | 2.38% |
#8
7
Prev: #15
|
4.6 |
—
|
550,000 | 203.7% |
P
S
|
820,000 | $4,346,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 3.46% | 1.31% |
#9
18
Prev: #27
|
4.4 |
—
|
124,250 | 248.5% |
P
S
|
174,250 | $3,650,538 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 3.29% | — |
#10
Prev: #—
|
4.8 |
—
|
55,350 | — |
NEW
|
55,350 | $3,470,445 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 3.16% | 2.64% |
#11
1
Prev: #12
|
3.3 |
—
|
7,400 | 14.8% |
P
S
|
57,400 | $3,335,514 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.12% | — |
#12
Prev: #—
|
4.7 |
—
|
82,000 | — |
NEW
|
82,000 | $3,298,860 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 3.11% | — |
#13
Prev: #—
|
4.7 |
—
|
110,700 | — |
NEW
|
110,700 | $3,288,897 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 3.08% | — |
#14
Prev: #—
|
4.7 |
—
|
174,250 | — |
NEW
|
174,250 | $3,248,020 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 2.72% | 2.04% |
#15
3
Prev: #18
|
1.6 |
—
|
-90,000 | -6.8% |
P
S
|
1,230,000 | $2,878,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 2.67% | — |
#16
Prev: #—
|
4.6 |
—
|
57,400 | — |
NEW
|
57,400 | $2,821,784 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 2.59% | 4.89% |
#17
12
Prev: #5
|
1.0 |
—
|
-37,000 | -23.1% |
P
S
|
123,000 | $2,737,980 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 2.56% | — |
#18
Prev: #—
|
4.5 |
—
|
451,000 | — |
NEW
|
451,000 | $2,701,490 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 2.10% | — |
#19
Prev: #—
|
4.3 |
—
|
82,000 | — |
NEW
|
82,000 | $2,221,380 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 2.08% | 2.47% |
#20
7
Prev: #13
|
2.8 |
—
|
12,000 | 17.1% |
P
S
|
82,000 | $2,200,060 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 2.03% | — |
#21
Prev: #—
|
4.3 |
—
|
102,500 | — |
NEW
|
102,500 | $2,141,225 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CPRX
CATALYST PHARMA...
|
Healthcare | 1.92% | — |
#22
Prev: #—
|
4.3 |
—
|
82,000 | — |
NEW
|
82,000 | $2,030,320 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 1.87% | — |
#23
Prev: #—
|
4.2 |
—
|
49,200 | — |
NEW
|
49,200 | $1,972,428 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 1.76% | — |
#24
Prev: #—
|
4.2 |
—
|
142,000 | — |
NEW
|
142,000 | $1,854,520 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 1.61% | — |
#25
Prev: #—
|
4.1 |
—
|
5,125 | — |
NEW
|
5,125 | $1,695,709 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LGND
LIGAND PHARMACE...
|
Healthcare | 1.55% | — |
#26
Prev: #—
|
4.1 |
—
|
8,200 | — |
NEW
|
8,200 | $1,637,130 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.47% | 1.65% |
#27
5
Prev: #22
|
1.1 |
—
|
-8,800 | -15.2% |
P
S
|
49,200 | $1,549,800 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 1.43% | 0.96% |
#28
6
Prev: #34
|
3.6 |
—
|
73,750 | 92.2% |
P
S
|
153,750 | $1,512,900 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LXRX
LEXICON PHARMAC...
|
Healthcare | 1.33% | 1.16% |
#29
1
Prev: #30
|
1.0 |
—
|
22,000 | 2.5% |
P
S
|
902,000 | $1,407,120 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 1.29% | 1.58% |
#30
7
Prev: #23
|
2.5 |
—
|
7,400 | 14.8% |
P
S
|
57,400 | $1,367,842 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.23% | 1.50% |
#31
7
Prev: #24
|
0.5 |
—
|
-57,500 | -35.9% |
P
S
|
102,500 | $1,298,675 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 1.12% | 1.20% |
#32
3
Prev: #29
|
2.9 |
—
|
6,900 | 23.0% |
P
S
|
36,900 | $1,181,169 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 0.91% | 4.31% |
#33
27
Prev: #6
|
0.4 |
—
|
-575,750 | -76.8% |
P
S
|
174,250 | $965,345 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.78% | — |
#34
Prev: #—
|
3.8 |
—
|
24,600 | — |
NEW
|
24,600 | $819,672 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.70% | 1.67% |
#35
14
Prev: #21
|
0.3 |
—
|
-99,500 | -41.5% |
P
S
|
140,500 | $740,435 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 0.66% | 3.13% |
#36
27
Prev: #9
|
0.3 |
—
|
-25,750 | -71.5% |
P
S
|
10,250 | $698,333 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GOSS
GOSSAMER BIO IN...
|
Healthcare | 0.26% | — |
#37
Prev: #—
|
3.6 |
—
|
820,000 | — |
NEW
|
820,000 | $269,370 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.00% | 0.40% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-12,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.00% | 0.86% |
Sold All 😨
(Was: #37) |
0.0 |
—
|
-30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.00% | 0.87% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.00% | 0.93% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-30,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 0.97% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.00% | 1.13% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-24,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 1.14% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-88,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.00% | 1.22% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-5,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.00% | 1.32% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-70,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 0.00% | 1.44% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-50,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CORT
CALL
CORCEPT THERAPE...
|
CALL Option | 0.00% | 1.75% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-44,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSM
INSMED INC
|
Healthcare | 0.00% | 1.99% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-10,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APOG
APOGEE ENTERPRI...
|
Industrials | 0.00% | 2.16% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-25,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 56 holdings